Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
about
Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseElectrophoretic particle guidance significantly enhances olfactory drug delivery: a feasibility studyInhaled corticosteroids for asthma: impact of practice level device switching on asthma control.Evaluation of patient preference and willingness to pay for attributes of maintenance medication for chronic obstructive pulmonary disease (COPD).Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designInhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium.Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD ExacerbationConfidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease.Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.Nanosized rods agglomerates as a new approach for formulation of a dry powder inhalerChapter 9 - Nanoliposomal dry powder formulations.Aerosol delivery by an ultrasonic nebulizer during different mechanical ventilation settings in a lung model--a pilot study.Scintigraphic Assessment of Deposition of Radiolabeled Fluticasone Delivered from a Nebulizer and Metered Dose Inhaler in 10 Healthy Dogs.The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers
P2860
Q27012625-88DB42F5-BC5F-4A32-ADD3-BEEB1DC2226EQ28539362-8C903F7D-EADA-4443-99CD-B1C91C634F08Q33397155-3B701116-82B9-4611-99C2-FC08A484A8B0Q34558862-5A9A7069-7EBE-4F15-B5A4-BD262F286282Q35796474-4625BF0F-A1CA-404D-A1C0-70505223081CQ36024374-0D558F01-E5D1-411C-9A26-E0AE5A2BBDE5Q37077219-FABB7CDD-BFF0-4678-AD47-D5A66537D953Q37380396-B1D74DAA-3A0E-4C7B-B7C2-CBCFC80DB597Q37725928-2583EBAC-0F2E-4908-8F2D-B38505CA1A04Q38034220-D6889426-6AA6-42DB-9F5D-F7D3404D3317Q38604589-19E98AFE-0D74-4059-BD90-E08F9E815DA2Q41037310-D7D25D46-7AF7-4788-9AE2-2915B6786039Q41071899-E3466F1F-5867-4823-B3C1-FE22CE5A6264Q41845309-F7F23506-9C0E-4108-91D9-4CAE875D32C7Q42097420-EC9D9420-5CE5-4D18-A543-E8DBD99246B0Q42582758-B3259BF0-E00E-4224-B7D6-38D91F808D63Q47094992-1A549B74-E5DE-4AC1-AD21-BCE80116C1EBQ58131528-298BB067-9421-4A08-8241-637108B97D05
P2860
Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Comparing clinical features of ...... haler, and dry powder inhaler.
@ast
Comparing clinical features of ...... haler, and dry powder inhaler.
@en
type
label
Comparing clinical features of ...... haler, and dry powder inhaler.
@ast
Comparing clinical features of ...... haler, and dry powder inhaler.
@en
prefLabel
Comparing clinical features of ...... haler, and dry powder inhaler.
@ast
Comparing clinical features of ...... haler, and dry powder inhaler.
@en
P1433
P1476
Comparing clinical features of ...... nhaler, and dry powder inhaler
@en
P2093
David E Geller
P304
1313-21; discussion 1321-2
P577
2005-10-01T00:00:00Z